ASSOCIATION OF LOC387715 A69S GENOTYPE WITH VISUAL PROGNOSIS AFTER PHOTODYNAMIC THERAPY FOR POLYPOIDAL CHOROIDAL VASCULOPATHY

@article{Sakurada2010ASSOCIATIONOL,
  title={ASSOCIATION OF LOC387715 A69S GENOTYPE WITH VISUAL PROGNOSIS AFTER PHOTODYNAMIC THERAPY FOR POLYPOIDAL CHOROIDAL VASCULOPATHY},
  author={Yoichi Sakurada and T. Kubota and M. Imasawa and F. Mabuchi and N. Tanabe and H. Iijima},
  journal={Retina},
  year={2010},
  volume={30},
  pages={1616-1621}
}
Purpose: To investigate whether there is an association of the LOC387715 A69S genotype with visual prognosis after photodynamic therapy in eyes with polypoidal choroidal vasculopathy (PCV). Methods: Photodynamic therapy was repeated every 3 months until the disappearance of angiographic signs of active lesions in 71 eyes of 71 patients with PCV who were followed-up for at least 12 months. All patients were genotyped for LOC387715 A69S polymorphism (rs10490924, risk-allele T). Results: Although… Expand
Two-year visual outcome of polypoidal choroidal vasculopathy treated with photodynamic therapy combined with intravitreal injections of ranibizumab
Two-year visual outcome of ranibizumab in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 29 REFERENCES
Association of LOC387715 A69S with vitreous hemorrhage in polypoidal choroidal vasculopathy.
Two-year results of photodynamic therapy for polypoidal choroidal vasculopathy.
Recurrence of polypoidal choroidal vasculopathy after photodynamic therapy
...
1
2
3
...